Trial Profile
Drug effects for arterial disease patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2013
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms DEADP
- 09 Aug 2013 New trial record